How do I buy Edgewise Therapeutics (EWTX) stock?

You can purchase shares of Edgewise Therapeutics (NASDAQ:EWTX) through any online brokerage.View our list of the best stock brokerages

Who are Edgewise Therapeutics (EWTX) competitors?

Other companies in Edgewise Therapeutics’s space includes: Supernus Pharmaceuticals Inc (NASDAQ:SUPN), WAVE Life Sciences Ltd (NASDAQ:WVE), Tarsus Pharmaceuticals Inc (NASDAQ:TARS), Terns Pharmaceuticals Inc (NASDAQ:TERN) and ANI Pharmaceuticals Inc (NASDAQ:ANIP).

What is the forecast, or price target, for Edgewise Therapeutics (EWTX) stock?

Edgewise Therapeutics has a consensus price target of $37.30.

What is the current price for Edgewise Therapeutics (EWTX)?

The stock price for Edgewise Therapeutics (NASDAQ: EWTX) is $27.7 last updated January 14, 2026 at 7:55 PM EST.

Does Edgewise Therapeutics (EWTX) pay a dividend?

There are no upcoming dividends for Edgewise Therapeutics.

When is Edgewise Therapeutics (NASDAQ:EWTX) reporting earnings?

Edgewise Therapeutics does not have any upcoming earnings scheduled.

Is Edgewise Therapeutics (EWTX) going to split?

There is no upcoming split for Edgewise Therapeutics.

What sector and industry does Edgewise Therapeutics (EWTX) operate in?

Edgewise Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

Edgewise Therapeutics (EWTX) Stock Price, Quote, News & History

Bulls vs Bears

Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Name

Revenue

Change

Gross

Change

EBITDA

Change

EBIT

Change

Earnings

Change

About

Sector

Health Care

Industry

Pharmaceuticals

Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapie...

Comments